| # | Drug | Count |
|---|---|---|
| 0 | PREDNISONE | 5275 |
| 1 | RITUXIMAB | 4068 |
| 2 | INFLIXIMAB | 3945 |
| 3 | ACETAMINOPHEN | 3700 |
| 4 | METHOTREXATE SODIUM | 3297 |
| 5 | METHOTREXATE | 3136 |
| 6 | TOCILIZUMAB | 2907 |
| 7 | NIVOLUMAB | 2883 |
| 8 | PREGABALIN | 2839 |
| 9 | INFLIXIMAB-DYYB | 2813 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | INFLIXIMAB-DYYB | 2813 | 0.2420 |
| 1 | BENZNIDAZOLE | 15 | 0.2419 |
| 2 | BALOXAVIR MARBOXIL | 281 | 0.1811 |
| 3 | RITUXIMAB-PVVR | 92 | 0.1623 |
| 4 | CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE | 38 | 0.1570 |
| 5 | TRIAMCINOLONE HEXACETONIDE | 31 | 0.1527 |
| 6 | CAFFEINE CITRATE | 116 | 0.1418 |
| 7 | C1 ESTERASE INHIBITOR RECOMBINANT | 300 | 0.1088 |
| 8 | HYDROXYPROPYL CELLULOSE | 32 | 0.1067 |
| 9 | PSEUDOEPHEDRINE HCL | 452 | 0.1017 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 8702 |
| 1 | Tumor Necrosis Factor Blocker [EPC] | 7133 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 6019 |
| 3 | CD20-directed Cytolytic Antibody [EPC] | 4624 |
| 4 | Platelet Aggregation Inhibitor [EPC] | 3809 |
| 5 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3238 |
| 6 | Folate Analog Metabolic Inhibitor [EPC] | 3133 |
| 7 | Benzodiazepine [EPC] | 2920 |
| 8 | Interleukin-6 Receptor Antagonist [EPC] | 2910 |
| 9 | Central Nervous System Stimulant [EPC] | 2835 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Melanin Synthesis Inhibitor [EPC] | 41 | 0.0485 |
| 1 | Vesicular Monoamine Transporter 2 Inhibitor [EPC] | 273 | 0.0400 |
| 2 | CTLA-4-directed Blocking Antibody [EPC] | 1135 | 0.0393 |
| 3 | Interleukin-6 Receptor Antagonist [EPC] | 2910 | 0.0347 |
| 4 | Interleukin-17 Receptor A Antagonist [EPC] | 27 | 0.0333 |
| 5 | Selective T Cell Costimulation Blocker [EPC] | 82 | 0.0297 |
| 6 | Programmed Death Receptor-1 Blocking Antibody [EPC] | 3238 | 0.0282 |
| 7 | Inactivated Influenza B Virus Vaccine [EPC] | 2 | 0.0278 |
| 8 | BCL-2 Inhibitor [EPC] | 687 | 0.0274 |
| 9 | Interleukin-1 Receptor Antagonist [EPC] | 289 | 0.0270 |